drugset / Trial / NCT03606681

Clinical and Radiographic Evaluation of Indirect Pulp Capping in Primary and Permanent Teeth With Different Materials

NCT03606681

RandomizedParallel-groupOpen-labelPrevention

Summary

Indirect pulp capping (IPC) is a treatment that preserves pulp's vitality. Several materials have been used for this procedure. The aim of this study is to evaluate the radiographic and clinical outcomes of TheraCal LC (Bisco Inc., Schaumburg, IL, USA) and to compare it with mineral trioxide aggregate (MTA) (Pro Root MTA, Dentsply Tulsa, Johnson City, TN, USA) and calcium hydroxide \[Ca(OH)2\] (Dycal, Dentsply De Trey Konstanz, Germany) biomaterials in IPC treatment.

Timeline

Start
2013-07
Primary completion
2014-06
Completion
2015-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium Hydroxide Other / unclassified
Subject Mineral Trioxide Aggregate Other / unclassified
Subject Theracal LC Other / unclassified

Indications